U.S. flag

An official website of the United States government

NM_000391.4(TPP1):c.1090G>A (p.Gly364Arg) AND Neuronal ceroid lipofuscinosis 2

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 14, 2020
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001278538.1

Allele description [Variation Report for NM_000391.4(TPP1):c.1090G>A (p.Gly364Arg)]

NM_000391.4(TPP1):c.1090G>A (p.Gly364Arg)

Gene:
TPP1:tripeptidyl peptidase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.4
Genomic location:
Preferred name:
NM_000391.4(TPP1):c.1090G>A (p.Gly364Arg)
HGVS:
  • NC_000011.10:g.6616060C>T
  • NG_008653.1:g.8402G>A
  • NM_000391.4:c.1090G>AMANE SELECT
  • NP_000382.3:p.Gly364Arg
  • LRG_830t1:c.1090G>A
  • LRG_830:g.8402G>A
  • LRG_830p1:p.Gly364Arg
  • NC_000011.9:g.6637291C>T
Protein change:
G364R
Links:
dbSNP: rs756237773
NCBI 1000 Genomes Browser:
rs756237773
Molecular consequence:
  • NM_000391.4:c.1090G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Neuronal ceroid lipofuscinosis 2
Synonyms:
JANSKY-BIELSCHOWSKY DISEASE NEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE; TPP1-Related Neuronal Ceroid-Lipofuscinosis
Identifiers:
MONDO: MONDO:0008769; MedGen: C1876161; Orphanet: 168491; Orphanet: 228349; Orphanet: 79264; OMIM: 204500

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001465555Natera, Inc.
no assertion criteria provided
Uncertain significance
(Apr 14, 2020)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Natera, Inc., SCV001465555.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024